Zobrazeno 1 - 4
of 4
pro vyhledávání: '"QuanHui Jiao"'
Autor:
Feifei Zhang, Jun Sun, Xiaofeng Tang, Yiping Liang, Quanhui Jiao, Bo Yu, Zhengzai Dai, Xuhui Yuan, Jiayu Li, Jinhua Yan, Zhiping Zhang, Song Fan, Min Wang, Haiyan Hu, Changhua Zhang, Xiao-Bin Lv
Publikováno v:
Cell Death and Disease, Vol 13, Iss 7, Pp 1-11 (2022)
Abstract Cytarabine (Ara-C) is the first-line drug for the treatment of acute myelogenous leukemia (AML). However, resistance eventually develops, decreasing the efficacy of Ara-C in AML patients. The expression of SAMHD1, a deoxynucleoside triphosph
Externí odkaz:
https://doaj.org/article/101ca85813a14cac8af3926a1c4e1656
Autor:
Xuhui Yuan, Cong Ma, Jiayu Li, Junhong Li, Ronghui Yu, Feng Cai, Gaoyang Qu, Bo Yu, Lang Liu, Duo Zeng, QuanHui Jiao, Qi Liao, Xiaobin Lv
Publikováno v:
Journal of Bone Oncology, Vol 39, Iss , Pp 100472- (2023)
Background: Osteosarcoma is most prevalently found primary malignant bone tumors, with primary metastatic patients accounting for approximately 25% of all osteosarcoma patients, yet their 5-year OS remains below 30%. Bilirubin plays a key role in oxi
Externí odkaz:
https://doaj.org/article/35b47a0499e74bbe98cc16d5a088d145
Autor:
Jiayu Li, Xuhui Yuan, Cong Ma, Junhong Li, Gaoyang Qu, Bo Yu, Feng Cai, Yuanxiang Peng, Lang Liu, Duo Zeng, QuanHui Jiao, Jiongfeng Zhang, Xiaohui Luo, Qi Liao, Xiao-Bin Lv
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveRecent knowledge concerning the significance of long non-coding RNA (lncRNA)-mediated ceRNA networks provides new insight into their possible roles as specific biomarkers for the treatment of osteosarcoma (OS). Thus, this study aims to clari
Externí odkaz:
https://doaj.org/article/2122c12f949b4ed0a8d623a7cf55a1fe
Autor:
Duo Zeng, Jiayu Li, Xuhui Yuan, Feng Cai, Bo Yu, Lang Liu, Qinchan Chen, FeiFei Zhang, Yiping Liang, Xiaofeng Tang, Yuanxiang Peng, Gaoyang Qu, Pengyun Wu, QuanHui Jiao, Longhua Sun, Xiao-Bin Lv, Qi Liao
Publikováno v:
Aging. 15:2450-2459